ResearcherUniversity of Southern CaliforniaNo recent work listed

Rishi Das

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5301-6223; OpenAlex author ID A5003067804. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. Co-author DOI 10.1016/j.adro.2023.101266 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Theodore Steven Lawrence · 1 shared paper, 2023 · strength 0.18
- Paper Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. DOI 10.1016/j.adro.2023.101266 ↗
Vaibhav Sahai · 1 shared paper, 2023 · strength 0.18
- Paper Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. DOI 10.1016/j.adro.2023.101266 ↗
Kyle Clifford Cuneo · 1 shared paper, 2023 · strength 0.18
- Paper Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. DOI 10.1016/j.adro.2023.101266 ↗
Filip Bednar · 1 shared paper, 2023 · strength 0.18
- Paper Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. DOI 10.1016/j.adro.2023.101266 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.